News

April 29, 2016April 29, 2016

Fibrocell’s Gene Therapy for Localized Scleroderma Designated an Orphan Drug by FDA

News, Scleroderma

Fibrocell Science, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has designated FCX-013 an orphan drug for the potential treatment of localized scleroderma, a chronic autoimmune disease in which the ... Read more

April 28, 2016April 28, 2016

Potential Target for Asthma Therapies Identified by University Researchers

Asthma, News

Researchers at Rutgers University and the University of Pennsylvania identified a biological pathway which may have a direct role in human asthma and airway hyper-responsiveness. The findings suggest that compounds that block ... Read more

April 28, 2016May 31, 2016

Scientists Discover Shared Genes in COPD and IPF, Pointing to Potential Drug Development

COPD, Emphysema, Idiopathic Pulmonary Fibrosis, News

Despite sharing some risk factors, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are usually studied in isolation, and the presence of possible shared molecular mechanisms has been unknown. Now, in a new study ... Read more

April 28, 2016April 28, 2016

European Committee Releases Positive Opinion on Cystic Fibrosis Drug for Orphan Medicinal Product

Cystic Fibrosis, News

Canada-based biotech Arch Biopartners announced the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has released a positive recommendation for the company’s treatment for infections linked to cystic fibrosis (CF). The ... Read more

April 27, 2016April 27, 2016

Physical Therapy Program Improves COPD Patients’ Quality of Life, Researchers Say

COPD, News

Researchers at the University of Granada (UGR) and Virgen de las Nieves Hospital, Spain, developed a brief physical therapy treatment of 7 to 10 days that demonstrates it can improve ... Read more

April 27, 2016April 28, 2016

New Insights into IPF Lung Disease Revealed with 3D Imaging Technique

Idiopathic Pulmonary Fibrosis, News

An advanced 3D X-ray imaging technique was applied for the first time to idiopathic pulmonary fibrosis (IPF) patients, providing new insight into how this aggressive disease develops in the body. The ... Read more

April 27, 2016May 13, 2016

Bedfont Scientific Recognizes World Asthma Day, Manufactures NObreath FeNO Test

Asthma, News

United Kingdom-based Bedfont Scientific, which is celebrating four decades in business this year, is recognizing World Asthma Day on May. The company manufactures NObreath FeNO Test, a fractional exhaled nitric oxide (FeNO) breath analysis ... Read more

April 26, 2016April 26, 2016

Propeller Health’s Digital Asthma Technology Gets High Marks in Controlled Study by Dignity Health

Asthma, News

Dignity Health, a national leader in healthcare systems, recently announced the results of a randomized, controlled study, indicating the use of digital health technology — namely the Propeller Health Asthma Platform — as an ... Read more

April 26, 2016April 28, 2016

Pulmonary Hypertension Association Launches ‘PH Care for All’ to Study Treatment Disparities

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) recently assembled 26 pulmonary hypertension (PH) specialists to launch “PH Care for All,” an initiative to examine and address treatment discrepancies for minorities and low-income ... Read more

April 26, 2016April 26, 2016

Aptar Introduces an eDose Counter Aiming to Make Asthma and COPD Inhalers Easier to Use

Asthma, COPD, News

Aptar Pharma, which specializes in injection, aerosol, and spray delivery systems for healthcare and biotech products, unveiled its newest improvement to metered dose inhaler (MDIs) at the recent RDD scientific conference in ... Read more